SCHEMBL7679341

SCHEMBL7679341

O=c1ccc(-c2ccccc2)nn1CCCN1CCN(c2cccc3ccccc23)CC1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.56
HTR7 P34969 4/20 0.56
DRD2 P14416 3/20 0.56
HTR2A P28223 3/20 0.56
HTR6 P50406 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.49
HTR2C P28335 1/20 0.49
DRD3 P35462 1/20 0.49
MAPT P10636 2/20 0.48
TP53 P04637 1/20 0.48
MEN1 O00255 1/20 0.48
CYP3A4 P08684 1/20 0.48
GAA P10253 1/20 0.48
CYP2D6 P10635 1/20 0.48
ALOX15 P16050 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681474 0.98 HTR1A (0.58) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL7681408 0.94 HTR1A (0.50) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL7681588 0.85 HTR1A (0.58) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL7681457 0.83 HTR1A (0.60) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL8101997 0.80 DRD4 (0.65) HTR1AHTR7DRD2HTR2ADRD3
SCHEMBL7689812 0.79 MAPT (0.73) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL7684230 0.78 HTR1A (0.52) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL7689917 0.77 MAPT (0.73) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL8598448 0.76 HTR1A (0.57) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL8102136 0.76 CTSS (0.67) HTR1AHTR7DRD2HTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413966-B1 SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. 2002-07-02 US claimed
EP-1057820-A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-12-06 EP claimed